
Dermacort0.05%
Ibn-Sina Pharmaceuticals Ltd.
Clobetasol Propionate [Topical Preparation] is a super-high-potency (Group I) topical corticosteroid.
Clobetasol Propionate [Topical Preparation] is a super-high-potency (Group I) topical corticosteroid. Its use is classified by strength of evidence as follows:
Clobetasol Propionate [Topical Preparation] is reserved for short courses on limited body-surface areas and is not intended for long-term or first-line use in mild skin conditions.
Clobetasol Propionate [Topical Preparation] must be used exactly as directed by a physician, on the smallest area and for the shortest duration necessary to control symptoms.
| Indication | Population | Typical Regimen |
|---|---|---|
| Corticosteroid-responsive dermatoses (eczema, localized psoriasis, lichen planus, discoid lupus) | Adults and adolescents ≥12 years | Apply a thin film to the affected area twice daily (morning and night); maximum 2 consecutive weeks; total weekly dose should not exceed 50 g (cream/ointment) or the equivalent for other forms |
| Plaque psoriasis (localized, up to 5–10% body surface area) | Adults ≥16–18 years, under specialist supervision | Twice daily application, may be extended up to 4 consecutive weeks with close monitoring; discontinue once control is achieved |
| Scalp conditions (using scalp solution/shampoo formulations) | Adults | Applied once or twice daily to the affected scalp area as directed on the product label; discontinue if no improvement after 1–2 weeks |
| Any indication | Children (where use is specifically directed by a physician) | Smallest effective amount, shortest possible course (often limited to about 5 days), under close medical supervision only |
Treatment should be reassessed if there is no improvement within 2 weeks. Clobetasol Propionate [Topical Preparation] should not be used with occlusive dressings unless specifically directed by a physician, and should not be applied to the face, groin, axillae, or other skin folds unless specifically instructed, due to increased absorption and risk of skin thinning in these areas.
Most side effects of Clobetasol Propionate [Topical Preparation] are local and occur at the application site. Systemic side effects are uncommon with short-term, limited-area use but become more likely with prolonged or extensive application.
Patients should contact their physician if any persistent, worsening, or unusual reaction occurs.
Clobetasol Propionate [Topical Preparation] is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.